Apply to trial NCT05337618

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Diagnostic test

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)

This study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patients who have undergone acute operative treatment of severe traumatic brain injury.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening